Spectroscopy Versus Standard Care in Cervical Cancer Patients
Cervical Cancer
About this trial
This is an interventional treatment trial for Cervical Cancer focused on measuring Cervical Intraepithelial Neoplasia, Cervical Dysplasia, Cervical Cancer, Fluorescence Spectroscopy, Colposcopy, Loop Electrical Excision Procedure, LEEP
Eligibility Criteria
Inclusion Criteria:
- Patients 18 years and older
- Non-pregnant
- Patients with abnormal smears with cervical intraepithelial neoplasia (both low grade squamous intraepithelial lesions and high grade squamous intraepithelial lesions equal to cervical intraepithelial neoplasia 1-3)
Exclusion Criteria:
- Patients who have had cytotoxic chemotherapy within 12-months prior to enrolling in this study, since the chemotherapy often induces change in the cervix.
Sites / Locations
- Lyndon Baines Johnson General Hospital
- UT MD Anderson Cancer Center
- British Columbia Cancer Research Centre
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Colposcopy
Colposcopy + Fluorescence Spectroscopy
Colposcopy + LEEP Procedure
Colposcopy - a direct magnified inspection of cervix
Colposcopy - a direct magnified inspection of cervix + Fluorescence Spectroscopy - electromagnetic spectroscopy which analyzes fluorescence from a sample.
Colposcopy - a direct magnified inspection of cervix + loop electrosurgical excision procedure (LEEP) - thin, low-voltage electrified wire loop to cuts out cervix abnormal tissue.